SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-001415
Filing Date
2015-02-27
Accepted
2015-02-27 16:51:31
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223147z10-k.htm 10-K 1555246
2 EX-10.63 a2223147zex-10_63.htm EX-10.63 22475
3 EX-21.1 a2223147zex-21_1.htm EX-21.1 5998
4 EX-23.1 a2223147zex-23_1.htm EX-23.1 3428
5 EX-31.1 a2223147zex-31_1.htm EX-31.1 7287
6 EX-31.2 a2223147zex-31_2.htm EX-31.2 7312
7 EX-32 a2223147zex-32.htm EX-32 5849
14 G238872.JPG g238872.jpg GRAPHIC 62057
15 G252242KEI001.JPG g252242kei001.jpg GRAPHIC 3301
16 G252242KEI002.JPG g252242kei002.jpg GRAPHIC 2374
  Complete submission text file 0001047469-15-001415.txt   14251124

Data Files

Seq Description Document Type Size
8 EX-101.INS thrx-20141231.xml EX-101.INS 2671923
9 EX-101.SCH thrx-20141231.xsd EX-101.SCH 74342
10 EX-101.CAL thrx-20141231_cal.xml EX-101.CAL 84367
11 EX-101.LAB thrx-20141231_lab.xml EX-101.LAB 715783
12 EX-101.PRE thrx-20141231_pre.xml EX-101.PRE 503070
13 EX-101.DEF thrx-20141231_def.xml EX-101.DEF 282596
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 15660067
SIC: 2834 Pharmaceutical Preparations